Skip to content

Urinary Continence of Female Pelvic Organ-preserving Radical Cystectomy with Orthotopic Ileal Neobladder: A Randomized Controlled Study

Urinary Continence of Female Pelvic Organ-preserving Radical Cystectomy with Orthotopic Ileal Neobladder: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059375
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Interventions

POPRC group:Pelvic organ-preserving radical cystectomy and orthotopic neobladder
SRC group:Standard radical cystectomy and orthotopic neobladder

Sponsors

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged between 55-75. 2. Patients who are diagnosed with organ-confined urothelial carcinoma(<pT3) 3. Patients who are capable of radical cystectomy with orthotopic ileal neobladder. 4. ECOG score between 0-2; 5. Normal renal function; 6. Patients who volunteer to participate in this study sign the informed consent. 7. Patients who are able to cooperate.

Exclusion criteria

Exclusion criteria: 1. Absence of tumour in bladder neck or urethra; 2. Patients who are diagnosed distant metastasis before surgery; 3. Previous history of malignancy of reproductive organs or surgical resection of reproductive organs; 4. Patients who are diagnosed with other malignancies; 5. Patients who had received pelvic radiotherapy or major pelvic operation; 6. Pregnancy status; 7. Any other conditions that the researcher considers to be excluded from this study.

Design outcomes

Primary

MeasureTime frame
Daytime and night-time continence rate [ Time Frame: 6 months ];

Secondary

MeasureTime frame
Postoperative sexual function [ Time Frame: 6 months ];Perioperative complication rate;5-year overall survival rate;5-year recurrence-free survival rate;Operative time;Estimated blood loss;

Countries

China

Contacts

Public ContactZhong Wenlong

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

zhongwlong3@mail.sysu.edu.cn+86 18510904167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026